TY - BOOK ID - 133940130 TI - The Prevention and Treatment of Atherosclerosis PY - 2022 PB - Basel MDPI - Multidisciplinary Digital Publishing Institute DB - UniCat KW - Research & information: general KW - familial hypercholesterolemia KW - genetic screening KW - atherosclerosis prevention KW - early detection KW - atherosclerosis KW - cigarette smoking KW - miR-27b KW - peripheral artery disease KW - subclinical atherosclerosis KW - SCORE KW - Framingham KW - QRISK KW - PROCAM KW - cardiovascular risk KW - pulse wave velocity KW - intima media thickness KW - malondialdehyde low-density lipoprotein KW - high-risk plaque KW - coronary computed tomography angiography KW - statin KW - cardiovascular risk factors KW - heart failure KW - major cardiac and cerebral ischemic events KW - degenerative aortic stenosis KW - risk stratification KW - vascular resistance KW - cardiovascular disease KW - acute myocardial infarction KW - intravascular imaging KW - statins KW - control-theoretic model KW - logistic growth KW - coronary artery disease KW - fibrin clot KW - fibrinolysis KW - thromboembolism KW - carotid intima-media complex KW - carotid plaque KW - major adverse cardiac and cerebral events KW - prevention KW - scores KW - vitamin D KW - myocardial infarction KW - males KW - Coronary Artery Surgery Study Score KW - n/a UR - https://www.unicat.be/uniCat?func=search&query=sysid:133940130 AB - This special issue of JCM ‘The Prevention and Treatment of Atherosclerosis’ will walk the Readers across novel diagnostic achievements in atherosclerosis and contemporary actions towards optimizing therapy.Everything begins with diagnosis. Accurate diagnostic tools and tests are of utmost importance. Contemporary research on microparticles, non-coding RNAs, proteomic characterization, …, offers detailed molecular characteristics of athero-thrombosis.Prevention is equally important as treatment. The impact of eating habits in prophylaxis of many pathologies, including cardiovascular disease has been documented.Then new pharmacological agents. Managing hypercholesterolemia with PCSK9 inhibitors, shown great potential in efficient lipid lowering to achieve LDL-C treatment goals, as well as reduction in cardiovascular mortality and morbidity.However, therapeutic goals accomplishment requires supervision. Arising number of data support that cardiovascular risk prediction can be improved with imaging modalities displaying atheroma: carotid plaque ultrasonography, coronary calcium score, intravascular ultrasonography, and optical coherent tomography or many others.As atherosclerosis is a progressive disease, it comes the time for more radical management, including endovascular and surgical intervention. There is field for new stent and equipment technologies, new surgical and endovascular techniques, supervision of endovascular procedures with IVUS, OCT, functional flow assessment or cell therapy.From diagnosis to risk stratification, elaborated prevention models, finally to modern and optimized therapeutic intervention. ER -